Witnessed by Dr. Rex Auyeung, Chairman of MTR Corporation (3rd right), and Mr. Andrew Liao, Council Chairman of HKUST (3rd left), Dr. Jacob Kam, Chief Executive Officer of MTR Corporation (2nd right), Ms. Margaret Cheng, Acting President of MTR Academy (1st right), Prof. Wei Shyy, President of HKUST (2nd left), and Prof. Lo Hong-Kam, Director of GREAT Smart Cities Institute of HKUST (1st left), signed the MoU on June 10, 2022.
Prof. Tim Cheang, Vice-President for Research and Development of HKUST and Center Director of ACCESS (left) and Dr. Denis Yip, Chief Executive Officer of ASTRI (right)
First InnoHK Research Center to Partner with ASTRI
Heading up a team of computer science professors and integrative systems designers at HKUST’s Center for Metaverse and Computational Creativity, Prof. Pan Hui (first left) is involved in the “MetaHKUST” project that will kick off with this September’s landmark grand opening of our new campus in Nansha, Guangzhou.
(From left) Bioengineering undergraduate students Cheng Ting-Kai, Minato Kobashi, and Mark Alexander Ngai won the Gold Award of HKUST President’s Cup 2022.
Study co-leads Prof. Qu Jianan (first right), Professor at Department of Electronic and Computer Engineering (ECE), and Prof. Liu Kai (first left), Associate Professor at Division of Life Science; as well as the first author of the study Wu Wanjie (second right), PhD student of ECE.
(From left) Prof. Yeung King-Lun, Director of HKUST-CIL Joint Laboratory of Innovative Environmental Health Technologies (HKUST-CIL Lab); Mr. Hamilton Hung, Chief Marketing Officer of Chiaphua Industries Limited; Prof. Joseph Kwan and Prof. Han Wei, Associate Directors of HKUST-CIL Lab; and a research team member have improved the formula of the antimicrobial coating MAP-1, launched at the onslaught of the COVID-19 pandemic in early 2020, pushing the coating’s durability from three months to five years.
The research team found that despite the number of epitopes encompassing Omicron mutations are nonetheless notably higher than other virus variants, Omicron, like other variants, is still unlikely to escape human's T cell responses.
